Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FiteBac Dental is a biotechnology company specializing in the development of antimicrobial additives for dental and medical applications. The company's core technology, K18, is a quaternary ammonium silane that provides long-lasting antimicrobial properties when incorporated into dental materials like composites, adhesives, and sealants. Their flagship product, the FiteBac Dental Cavity Cleanser, is FDA-cleared and designed to disinfect tooth preparations while strengthening the bond between the tooth and restorative materials. FiteBac Dental aims to reduce secondary caries and improve the longevity of dental restorations through its innovative molecular-level antimicrobial solutions. The company actively collaborates with major dental manufacturers to integrate its non-leaching antimicrobial technology into a wide range of clinical products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FiteBac Dental.